NL195084C - Gevormd farmaceutisch preparaat omvattende een beta2#-sympathomimetische bronchodilatator. - Google Patents

Gevormd farmaceutisch preparaat omvattende een beta2#-sympathomimetische bronchodilatator.

Info

Publication number
NL195084C
NL195084C NL9200629A NL9200629A NL195084C NL 195084 C NL195084 C NL 195084C NL 9200629 A NL9200629 A NL 9200629A NL 9200629 A NL9200629 A NL 9200629A NL 195084 C NL195084 C NL 195084C
Authority
NL
Netherlands
Prior art keywords
beta2
pharmaceutical preparation
formed pharmaceutical
sympathomimetic bronchodilator
sympathomimetic
Prior art date
Application number
NL9200629A
Other languages
English (en)
Other versions
NL9200629A (nl
Inventor
John Morley
Original Assignee
Sepracor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor filed Critical Sepracor
Publication of NL9200629A publication Critical patent/NL9200629A/nl
Application granted granted Critical
Publication of NL195084C publication Critical patent/NL195084C/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL9200629A 1991-04-05 1992-04-03 Gevormd farmaceutisch preparaat omvattende een beta2#-sympathomimetische bronchodilatator. NL195084C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919107196A GB9107196D0 (en) 1991-04-05 1991-04-05 Improvements in or relating to organic compounds
GB9107196 1991-04-05

Publications (2)

Publication Number Publication Date
NL9200629A NL9200629A (nl) 1992-11-02
NL195084C true NL195084C (nl) 2003-10-02

Family

ID=10692709

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9200629A NL195084C (nl) 1991-04-05 1992-04-03 Gevormd farmaceutisch preparaat omvattende een beta2#-sympathomimetische bronchodilatator.

Country Status (10)

Country Link
US (3) US20020132830A1 (nl)
JP (3) JPH0597707A (nl)
BE (1) BE1005778A5 (nl)
CA (1) CA2065051C (nl)
CH (1) CH685672A5 (nl)
DE (1) DE4209989A1 (nl)
FR (1) FR2674751B1 (nl)
GB (2) GB9107196D0 (nl)
IT (1) IT1254317B (nl)
NL (1) NL195084C (nl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0509036T3 (da) * 1990-01-05 1996-07-29 Sepracor Inc Optisk ren R(-)-albuterol til behandling af astma
US5362755A (en) * 1990-01-05 1994-11-08 Sepracor, Inc. Method for treating asthma using optically pure (R)-albuterol
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US6866839B2 (en) 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US6299863B1 (en) 1992-04-03 2001-10-09 Sepracor Inc. Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
SE9604752D0 (sv) * 1996-12-20 1996-12-20 Astra Ab Formulation and use
US6254882B1 (en) * 1997-09-16 2001-07-03 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US6303145B2 (en) 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
US6369115B1 (en) 2000-03-20 2002-04-09 Dura Pharmaceuticals, Inc. Stabilized powder formulations
MXPA05000028A (es) * 2002-06-20 2005-08-26 Nippon Suisan Kaisha Ltd Profarmaco, uso medicinal del mismo y procedimiento para producir el mismo.
US7495028B2 (en) 2002-08-08 2009-02-24 Wen Tan R-bambuterol, its preparation and therapeutic uses
JP4979889B2 (ja) * 2002-08-08 2012-07-18 タン,ダブリュー. R型バンブテロール又はその薬学的に許容される塩の製造方法
EP1754474A1 (en) * 2005-02-02 2007-02-21 Eucro European Contract Research GmbH & Co. KG Use of S-Clenbuterol
EP1719507B1 (en) * 2005-04-13 2010-07-14 Astion Development A/S Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
EP2064174B1 (en) 2006-08-10 2016-10-26 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Preparation of (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
CN102448309A (zh) * 2009-06-16 2012-05-09 谭文 左旋(r)班布特罗在制备治疗呼吸性疾病的吸入性药物制剂和药物组合中的应用
WO2011112867A1 (en) 2010-03-10 2011-09-15 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
US8394829B2 (en) 2010-05-10 2013-03-12 Gilead Sciences, Inc. Bi-functional quinoline analogs
WO2011143106A1 (en) 2010-05-10 2011-11-17 Gilead Sciences, Inc. Bi - functional pyrazolopyridine compounds
CA2891234C (en) 2012-12-03 2017-03-07 Pfizer Inc. Selective androgen receptor modulators
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300751A (nl) * 1962-11-30 1900-01-01
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
US3885047A (en) * 1972-06-16 1975-05-20 Mead Johnson & Co Ocular hypotensive process employing dextrorotatory phenethanolamines
US4119710A (en) * 1972-12-18 1978-10-10 Boehringer Ingelheim Gmbh Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts
US3985897A (en) * 1973-12-21 1976-10-12 Mead Johnson & Company Ocular hypotensive process employing dextrorotatory sulfonamidophenethanolamines
DK0509036T3 (da) * 1990-01-05 1996-07-29 Sepracor Inc Optisk ren R(-)-albuterol til behandling af astma
US5362755A (en) * 1990-01-05 1994-11-08 Sepracor, Inc. Method for treating asthma using optically pure (R)-albuterol
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Also Published As

Publication number Publication date
JPH0597707A (ja) 1993-04-20
US20060094701A1 (en) 2006-05-04
GB9207363D0 (en) 1992-05-13
JP2008019281A (ja) 2008-01-31
BE1005778A5 (fr) 1994-01-25
FR2674751A1 (fr) 1992-10-09
CA2065051A1 (en) 1992-10-06
GB2255503B (en) 1995-12-06
JP2004196821A (ja) 2004-07-15
DE4209989A1 (de) 1992-10-08
ITRM920237A1 (it) 1993-10-02
GB2255503A (en) 1992-11-11
NL9200629A (nl) 1992-11-02
US20040192783A1 (en) 2004-09-30
CH685672A5 (de) 1995-09-15
IT1254317B (it) 1995-09-14
GB9107196D0 (en) 1991-05-22
US20020132830A1 (en) 2002-09-19
CA2065051C (en) 2004-08-24
ITRM920237A0 (it) 1992-04-02
FR2674751B1 (fr) 1995-05-05

Similar Documents

Publication Publication Date Title
NL195084C (nl) Gevormd farmaceutisch preparaat omvattende een beta2#-sympathomimetische bronchodilatator.
NO921958D0 (no) Farmasoeytisk preparat
NO922006D0 (no) Farmasoeytisk preparat
NL194781B (nl) Farmaceutisch preparaat voor orale toediening dat een cyclosporine bevat.
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
FI922958A0 (fi) Farmaceutisk sammansaettning.
FI903382A0 (fi) Topiskt anbringbara farmaceutiska preparat.
CY2004005I1 (el) Σουλφοναμιδη, η παρασκευη και χρηση της ως φαρμακου και ενδιαμεσης ουσιας
DE68911473D1 (de) Arzneimittelformulierungen.
FI923581A0 (fi) Farmaceutisk kombinationsformation.
DE69231965T2 (de) Pharmazeutische formulierungen
NO962694D0 (no) Percutant farmasöytisk preparat
NO943888D0 (no) Farmasöytisk preparat
PT100814A (pt) Formulacoes transdermica para a administracao de prazosina
FI891227A0 (fi) Katekolderivat och farmaceutiska preparat som innehaoller dessa.
FI890488A (fi) Vaextextrakt innehaollande farmaceutiska preparat samt foerfarande foer framstaellning daerav.
DK0587047T3 (da) Farmaceutisk præparat på gestagenbasis
EP0423238A4 (en) Synthetic vaccine against p. falciparum malaria
EP0216901A4 (en) ANTIGEN-CARRIER IMMUNOGENIC PROTEIN CONJUGATE FOR USE IN A MALARIA VACCINE.
FI874382A (fi) Farmaceutiska preparat.
FI921786A0 (fi) Farmaceutisk foerening.
DE58905160D1 (de) Pharmazeutische zubereitung.
FI921785A0 (fi) Farmaceutisk foerening.
AU1108192A (en) A plasmodium falciparum blood-stage antigen, the preparation and use thereof
FI894347A0 (fi) 2,3,4,5-tetrahydro-1-benzoxepiner, foerfarande foer deras framstaellning, deras anvaendning och dessa foereningar innehaollande farmaceutiska preparat.

Legal Events

Date Code Title Description
NP1 Patent granted (not automatically)
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20120403